Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP3 | P08254 | 14/20 | 1.00 |
| ▸ | MMP2 | P08253 | 12/20 | 1.00 |
| ▸ | MMP1 | P03956 | 2/20 | 0.86 |
| ▸ | MMP9 | P14780 | 2/20 | 0.86 |
| ▸ | MMP14 | P50281 | 2/20 | 0.86 |
| ▸ | DHODH | Q02127 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | MMP13 | P45452 | 1/20 | 0.37 |
| ▸ | CTPS1 | P17812 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethylamine SCHEMBL6974207 | 0.98 | MMP3 (0.97) | MMP3MMP2MMP1MMP9MMP14 | |
| SCHEMBL6585851 | 0.92 | MMP3 (1.00) | MMP3MMP2MMP1MMP9MMP14 | |
| SCHEMBL6973528 | 0.91 | MMP3 (1.00) | MMP3MMP2MMP1MMP9MMP14 | |
| SCHEMBL6586804 | 0.91 | MMP3 (1.00) | MMP3MMP2MMP1MMP9MMP14 | |
| SCHEMBL6586134 | 0.91 | MMP3 (0.83) | MMP3MMP2MMP1MMP9MMP14 | |
| SCHEMBL6587846 | 0.91 | MMP2 (0.83) | MMP3MMP2MMP1MMP9MMP14 | |
| SCHEMBL7408826 | 0.91 | MMP2 (0.82) | MMP3MMP2MMP1MMP9MMP14 | |
| Hydrochloric Acid SCHEMBL6971643 | 0.90 | MMP3 (0.98) | MMP3MMP2MMP1MMP9MMP14 | |
| SCHEMBL6972635 | 0.90 | MMP3 (1.00) | MMP3MMP2MMP1MMP9MMP14 | |
| Hydrochloric Acid SCHEMBL6962275 | 0.90 | MMP3 (0.98) | MMP3MMP2MMP1MMP9MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1036062-B1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LTD (GB) | 2004-01-02 | — | — | EP | claimed |
| US-6495568-B1 | TREATMENT OF TISSUE ULCERATION, WOUND REPAIR AND SKIN DISEASES | WARNER-LAMBERT COMPANY | 2002-12-17 | — | — | US | claimed |
| EP-1036062-A1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | Pfizer Limited (GB) | 2000-09-20 | — | — | EP | claimed |
| WO-1999029667-A1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LIMITED (GB) | 1999-06-17 | — | — | WO | claimed |
| EP-1036062-B1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LTD (GB) | 2004-01-02 | — | — | EP | disclosed |
| US-6495568-B1 | TREATMENT OF TISSUE ULCERATION, WOUND REPAIR AND SKIN DISEASES | WARNER-LAMBERT COMPANY | 2002-12-17 | — | — | US | disclosed |
| EP-1036062-A1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | Pfizer Limited (GB) | 2000-09-20 | — | — | EP | disclosed |
| WO-1999029667-A1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LIMITED (GB) | 1999-06-17 | — | — | WO | disclosed |